DPO™ Technology, Super Multiplex PCR!
Novel Oligo Platform for PCR: DPO™

DPO™ technology is a fundamental tool for blocking extention of non-specifically primed templates generating consistently high specificity. The strength and utility of this DPO™ technology can be successfully in corporated into molecular diagnostics systems such as multiplex diagnostics and SNP genotyping systems.

URL: http://www.seegene.com/en/service/dso_1.php
 
 
 

 Microsynth : The Swiss DNA Company

Microsynth (founded in 1989) is a leading European company in the area of nucleic acid synthesis & analysis. The main activities are divided into following three business areas:
 
1.DNA/RNA Synthesis
2.DNA/RNA Analysis and Sequencing
3.Contract Research/Outsourcing

For almost three decades, the companys' objective has been to serve its customers by delivering products and services of the highest quality, on time and with outstanding service – and all this at competitive prices.
 
URL: Microsynth Site
 
 
 

Consultant
Research & Innovation Japan Inc.

Consultation in biotech and in vitro diagnostic business
 

What is the outline of RIJ’s consultant business?

RIJ is a consulting company for biotechnology and in vitro diagnostics. RIJ prepares the launch pad for foreign companies to introduce their products in the Japanese market. The main activity of RIJ is to offer consulting services to foreign companies
who want to bring their products with a unique technology to Japan. RIJ advises the companies on the modalities of the Japanese market and assist in the promotion, marketing and distribution of the foreign company’s products in Japan.

 

How does RIJ make leverage on this consulting business?

The market in Japan comprises of small-, medium-and large-scale manufacturers of diagnostics and biotechnology products. Japan is also filled
with wholesalers who distribute the products to the end-users. RIJ’s role is to act as a bridge between the manufacturer and wholesaler. In addition, RIJ advises local manufacturers who wish to expand their technology to overseas market. It is RIJ’s responsibility to identify the right distributor both within and outside the boundaries of Japan (please see attached article).
Mr. K.Hirasawa, CEO of RIJ was in Boehringer Mannheim kk and Roche Diagnostic Inc for 25 years totally. And he is now a Business Adviser of Foundation Innovative New Diagnostics(FIND) in Japan.

Please contact us. RIJ will help your firm to find appropriate marketing partner to make your business successfully in Japan. 
 
downlord (200KB)